Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CRCT vs BGIN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRCT Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

CRCT Overall Winner 6-Pillar Tally: CRCT 6 – 0 BGIN Matrix Metrics: CRCT 10 – 0 BGIN

As of Nov 20, 2026, Cricut, Inc. (CRCT) is the stronger overall head-to-head candidate over BGIN (BGIN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRCT carries a Unified Composite Score of 41.5/100 (SELL) at $8.35 (29.2x Forward P/E, 15.5% operating margin), whereas BGIN carries 34.4/100 (SELL) at $4.81 (N/M Forward P/E, -418.3% operating margin).

  • Defensive Composite Rating Caution: Although CRCT compares more favorably head-to-head, both CRCT (41.5/100 SELL) and BGIN (34.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRCT vs BGIN
CRCT NASDAQ Head-to-Head Winner
Cricut, Inc. Class A Common Stock
Special Industry Machinery, Nec
$8.35
+0.6% 1D
Market Cap $1.7B
TTM Revenue $708M
Forward P/E 29.2x
Beta / 30D Vol 0.74β · 171% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 15.0 Fund 36.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (14.3% over 20 days), RSI 61
RSI-14: 61.2 · SMA20: $7.78 · SMA50: $6.84
BGIN US Equity
BGIN
Institutional Equity
$4.81
-14.26% 1D
Market Cap $634.7M
TTM Revenue $27M
Forward P/E N/M
Beta / 30D Vol 1.03β · 254% Vol
Unified Composite Score
34.4 / 100 SELL
Tech 50.0 Fund 37.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (15.2% over 20 days), RSI 72
RSI-14: 72.4 · SMA20: $2.78 · SMA50: $2.33

6-Pillar Scorecard Institutional Category Breakdown (CRCT 6 – 0 BGIN)

Columns: Metric · CRCT · BGIN
1. Valuation Multiples CRCT
Forward P/E 29.2x N/M
Trailing P/E 18.9x N/M
PEG Ratio N/M N/M
EV / Revenue 2.2x 23.4x
2. Growth & Scale CRCT
Revenue Growth (YoY) +10.7% -84.5%
Earnings Growth (YoY) +34.5% +0.0%
TTM Revenue (USD) $708M $27M
Market Cap $1.7B $634.7M
3. Profitability & Quality CRCT
Gross Margin 57.4% N/A
Operating Margin 15.5% -418.3%
Net Profit Margin 13.4% 0.0%
Return on Equity (ROE) 25.1% -161.9%
4. Balance Sheet & Cash Flow CRCT
Cash Generation (TTM) $148M -$100M EBITDA
Cash Flow Margin 20.8% N/A
Net Cash / Leverage $165M Net Cash $0.26 Book/Sh · -161.9% ROE
Dividend Yield 2.34% None (0.00%)
5. Options & Positioning CRCT
Options Structure Phase SURGE UNCLASSIFIED
Current IV / %ile 53.2% (3rd %ile) N/A (N/A)
Put/Call OI Skew 1.39x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat CRCT
OpEx & R&D Intensity 41.9% of Rev ($297M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Computer Hardware Operator Computer Hardware Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRCT (10) vs BGIN (0)
Institutional Metric CRCT BGIN Criterion Row Edge
Market Capitalization
Scale
$1.7B $634.7M Larger Scale CRCT
Trailing P/E Ratio
Valuation
18.9x N/M Lower Multiple CRCT
Forward P/E Ratio
Valuation
29.2x N/M Lower Multiple CRCT
Revenue Growth (YoY)
Growth
+10.7% -84.5% Higher Growth CRCT
Operating Margin (TTM)
Profitability
15.5% -418.3% Higher Margin CRCT
Net Profit Margin
Profitability
13.4% 0.0% Higher Margin CRCT
Return on Equity (ROE)
Capital Efficiency
25.1% -161.9% Higher ROE CRCT
52-Week Range Position
Momentum
77% ($4–$10) 76% ($2–$6) Stronger Trend CRCT
Beta / 30D Volatility
Risk Regime
0.74β · 171% Vol 1.03β · 254% Vol Lower Realized Risk CRCT
Unified Institutional Score
Composite Signal
41.5 / 100 (SELL) 34.4 / 100 (SELL) Higher Composite CRCT
Trailing 12M Revenue (USD)
Operating Scale
$708M $27M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
57.4% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.2x EV/Rev N/M PEG · 23.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$148M ($165M Net Cash) -$100M EBITDA ($0.26 Book/Sh · -161.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BGIN +117.67 pp
CRCT: +30.27% · BGIN: +147.94%
3M Horizon BGIN +81.26 pp
CRCT: +47.79% · BGIN: +129.05%
6M Horizon CRCT +68.81 pp
CRCT: +108.23% · BGIN: +39.42%
1Y Horizon CRCT +29.13 pp
CRCT: +82.31% · BGIN: +53.18%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRCT vs BGIN. Trailing 12-month operating profitability (CRCT 15.5% vs BGIN -418.3%) and valuation multiples (CRCT 29.2x vs BGIN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CRCT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$708M
Gross Margin57.4%
Op. Margin15.5%
ROE / Fwd P/E25.1% · 29.2x
BGIN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$27M
Gross MarginN/A
Op. Margin-418.3%
ROE / Fwd P/E-161.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRCT SURGE
11d in phase · OBV NEUTRAL
Current IV 53.2%
IV Percentile 3rd %ile
Put/Call OI Skew 1.39x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRCT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BGIN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BGIN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRCT Moat Profile Scale & Operating Efficiency Moat
Computer Hardware Operator
Competes within the Computer Hardware value chain with $1.7B market capitalization and 15.5% operating margin.
OpEx & R&D Reinvestment 41.9% of Rev ($297M)
90D Engineering Disclosures 0 Published
BGIN Moat Profile Cyclical / Execution-Driven Positioning
Computer Hardware Operator
Competes within the Computer Hardware value chain with $634.7M market capitalization and -418.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CRCT vs BGIN Key Questions & Quantitative Answers

As of Nov 20, 2026, Cricut, Inc. (CRCT) is the stronger overall head-to-head candidate over BGIN (BGIN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRCT carries a Unified Composite Score of 41.5/100 (SELL) at $8.35 (29.2x Forward P/E, 15.5% operating margin), whereas BGIN carries 34.4/100 (SELL) at $4.81 (N/M Forward P/E, -418.3% operating margin). Defensive Composite Rating Caution: Although CRCT compares more favorably head-to-head, both CRCT (41.5/100 SELL) and BGIN (34.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

CRCT leads the Growth & Scale pillar: CRCT posts +10.7% YoY revenue growth and +34.5% YoY earnings growth on $708M TTM revenue (57.4% gross margin, 15.5% operating margin), compared with BGIN at -84.5% YoY revenue growth and +0.0% YoY earnings growth on $27M TTM revenue (N/A gross margin, -418.3% operating margin). On trailing 12-month operating scale, CRCT generates $708M in USD-normalized revenue versus $27M for BGIN. In operating R&D and SG&A reinvestment, CRCT deploys 41.9% of Rev ($297M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BGIN.

CRCT screens cheaper on headline valuation multiples. CRCT trades at 29.2x Forward P/E, 18.9x Trailing P/E, N/M PEG, and 2.2x EV/Revenue (20.8% FCF margin), whereas BGIN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 23.4x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRCT (25.1% ROE) versus BGIN (-161.9% ROE) capital efficiency.

In options market volatility and institutional positioning, CRCT carries 53.2% implied volatility (3rd %ile, Compressed (<25th %ile)), a 1.39x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.74β · 171% Vol realized risk). By comparison, BGIN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 254% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.